Title:
TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS
Document Type and Number:
WIPO Patent Application WO/2024/035757
Kind Code:
A3
Abstract:
Novel tryptamine compounds according to Formulas (1), (2), (3), (4), (5), and (6) and sub-formulas thereof, pharmaceutical salts thereof, and pharmaceutical compositions thereof, and methods of treating mood disorders, including depressive disorders and bipolar disorders, comprising administering a therapeutically effective amount of a compound according to any one of Formulas (1), (2), (3), (4), (5), and (6) or a pharmaceutical composition thereof to a subject in need thereof.
Inventors:
KRUEGEL ANDREW CARRY (US)
CUNNINGHAM MICHAEL (US)
CUNNINGHAM MICHAEL (US)
Application Number:
PCT/US2023/029799
Publication Date:
March 14, 2024
Filing Date:
August 09, 2023
Export Citation:
Assignee:
GILGAMESH PHARMACEUTICALS INC (US)
International Classes:
A61K31/4045; A61K31/395; C07D209/04; C07D209/16; A61K31/33
Foreign References:
| US20180221396A1 | 2018-08-09 | |||
| US20200345585A1 | 2020-11-05 |
Other References:
WINN ET AL.: "N-Cyclopropyltryptamines, Potent Monoamine Oxidase Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 18, no. 4, 1975, pages 437 - 438, XP002533880, DOI: 10.1021/jm00238a025
TANAKA ET AL.: "Identification of six tryptamine derivatives as designer drugs in illegal products", FORENSIC TOXICOLOGY, vol. 39, pages 248 - 258, XP037331189, DOI: 10.1007/s11419-020-00556-5
TANAKA ET AL.: "Identification of six tryptamine derivatives as designer drugs in illegal products", FORENSIC TOXICOLOGY, vol. 39, pages 248 - 258, XP037331189, DOI: 10.1007/s11419-020-00556-5
Attorney, Agent or Firm:
GROLZ, Edward (US)
Download PDF: